Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009

Conference Report

Authors

  • Werner Neidhart
  • Hans Peter Märki
  • Peter Mohr

DOI:

https://doi.org/10.2533/chimia.2009.573

Keywords:

Atherosclerosis, Drug targeting, Highlights in medicinal chemistry, Inflammatory diseases, Kinases, Nanomedicine, Neuropsychiatry, New technologies, Nuclear hormone receptors, Proteomics

Abstract

'Frontiers in Medicinal Chemistry 2009' was organized as a joint German-Swiss meeting at the University of Heidelberg. It covered the areas of kinases and nuclear hormone receptors, inflammatory diseases, atherosclerosis and neuropsychiatry. Special sessions were dedicated to new technologies in nanomedicine, proteomics and drug targeting. A session on highlights in medicinal chemistry completed the program. The lectures covered a broad range of interdisciplinary topics including molecular design and lead optimization programs, development and application of new technologies in proteomics, drug delivery & chemical synthesis.
CHIMIA Vol. 63 No. 9 (2009): Aspects of Chemistry at UZH from Werner to the Present Day

Downloads

Published

2009-09-23

How to Cite

[1]
W. Neidhart, H. P. Märki, P. Mohr, Chimia 2009, 63, 573, DOI: 10.2533/chimia.2009.573.

Issue

Vol. 63 No. 9 (2009): Aspects of Chemistry at UZH from Werner to the Present Day

Section

Columns, Conference Reports

Categories

License

Copyright (c) 2009 Swiss Chemical Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.